ClinicalTrials.govpublic full text
A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients
epithelial cancer patients, cancer, neoplasm, carcinoma, intravenous, monoclonal antibody, removab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.